These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12538008)
1. Syntheses of 3-carbomethoxy-4-(aryl)piperidines and in vitro and in vivo pharmacological evaluation: identification of inhibitors of the human dopamine transporter. Feng X; Fandrick K; Johnson R; Janowsky A; Cashman JR Bioorg Med Chem; 2003 Mar; 11(5):775-80. PubMed ID: 12538008 [TBL] [Abstract][Full Text] [Related]
2. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors. Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754 [TBL] [Abstract][Full Text] [Related]
3. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton. Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters. Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876 [TBL] [Abstract][Full Text] [Related]
5. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo. Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032 [TBL] [Abstract][Full Text] [Related]
6. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473 [TBL] [Abstract][Full Text] [Related]
7. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters. Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel partial inhibitor of dopamine transporter among 4-substituted 2-phenylquinazolines. Ananthan S; Saini SK; Khare R; Clayton SD; Dersch CM; Rothman RB Bioorg Med Chem Lett; 2002 Aug; 12(16):2225-8. PubMed ID: 12127543 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors. Tamiz AP; Bandyopadhyay BC; Zhang J; Flippen-Anderson JL; Zhang M; Wang CZ; Johnson KM; Tella S; Kozikowski AP J Med Chem; 2001 May; 44(10):1615-22. PubMed ID: 11334571 [TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel dopamine transporter inhibitor, 4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships, and behavioral pharmacological studies. Wang S; Sakamuri S; Enyedy IJ; Kozikowski AP; Deschaux O; Bandyopadhyay BC; Tella SR; Zaman WA; Johnson KM J Med Chem; 2000 Feb; 43(3):351-60. PubMed ID: 10669562 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes. Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacology of site specific cocaine abuse treatment agents: 8-substituted isotropane (3-azabicyclo[3.2.1]octane) dopamine uptake inhibitors. Kim DI; Schweri MM; Deutsch HM J Med Chem; 2003 Apr; 46(8):1456-64. PubMed ID: 12672245 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate. Meltzer PC; Wang P; Blundell P; Madras BK J Med Chem; 2003 Apr; 46(8):1538-45. PubMed ID: 12672255 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter. Dutta AK; Reith ME; Madras BK Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505 [TBL] [Abstract][Full Text] [Related]
15. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter. Dutta AK; Xu C; Reith ME J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474 [TBL] [Abstract][Full Text] [Related]
16. 3-Aryl-2-carbomethoxybicyclo[3.2.1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter. Meltzer PC; Blundell P; Huang H; Liu S; Yong YF; Madras BK Bioorg Med Chem; 2000 Mar; 8(3):581-90. PubMed ID: 10732975 [TBL] [Abstract][Full Text] [Related]
17. Expansion of structure-activity studies of piperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (GBR 12935) compounds by altering substitutions in the N-benzyl moiety and behavioral pharmacology of selected molecules. Dutta AK; Davis MC; Fei XS; Beardsley PM; Cook CD; Reith ME J Med Chem; 2002 Jan; 45(3):654-62. PubMed ID: 11806716 [TBL] [Abstract][Full Text] [Related]
18. 2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies. el-Moselhy TF; Avor KS; Basmadjian GP Arch Pharm (Weinheim); 2001 Sep; 334(8-9):275-8. PubMed ID: 11688137 [TBL] [Abstract][Full Text] [Related]
19. 2,3-disubstituted 6-azabicyclo[3.2.1]octanes as novel dopamine transporter inhibitors. Quirante J; Vila X; Bonjoch J; Kozikowski AP; Johnson KM Bioorg Med Chem; 2004 Mar; 12(6):1383-91. PubMed ID: 15018911 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine. Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]